The World Health Organization (WHO) and the Yobe State government have initiated a comprehensive vaccination campaign against cervical cancer, specifically targeting female children aged 9 to 14 years old.
Dr. Alhassan Hamisu Dama, the WHO Coordinator for Yobe State, underscored the critical importance of this initiative, highlighting that cervical cancer is the second leading cause of cancer deaths among women aged 15-49 in Nigeria, with approximately 12,075 new cases reported annually.
“Human HPV infection is a high-risk factor implicated in 95% of cervical cancer cases. Studies show that vaccination against HPV can reduce the incidence by 83% among girls aged 13-19,” Dr. Dama stated. The campaign aims to reach 565 schools and community teams across Yobe State, vaccinating girls both in educational institutions and in out-of-school camps over the next five days.
Dr. Dama emphasized the thorough nature of the campaign, explaining, “From pre-implementation training at national, state, LGA, and ward levels to implementation and post-implementation activities, including post-campaign spot-checks, WHO will be investing resources to ensure the campaign’s success.”
The WHO’s efforts in Yobe State are part of a broader commitment to support the state’s healthcare system and improve overall public health outcomes. This campaign is designed not only to provide immediate protection against HPV but also to establish a sustainable framework for ongoing health initiatives.
Dr. Muhammad Lawan Gana, the Commissioner for Health and Human Services, affirmed the state government’s dedication to achieving universal health coverage and advancing sustainable health development goals. He praised the collaborative efforts that have made this campaign possible, reflecting a strong partnership between local government and international organizations.
Hajiya Ya Jalo Badama, the Commissioner of Women Affairs, formally integrated the HPV vaccine into the state’s routine immunization programs. She lauded the cooperative efforts between the government and development partners in combating cervical cancer and other HPV-related diseases.
